Trump Touts Lower Prices, Medicare Coverage for Weight-Loss Drugs in Deals with Eli Lilly, Novo Nordisk
- November 07, 2025
Eli Lilly and Company and Novo Nordisk have struck deals with the Trump administration to lower prices for their popular weight-loss medications in exchange for a three-year reprieve from tariffs and broader Medicare coverage of GLP-1s.
ARTICLE TAGS
You must be logged in to access this content.